Teams at Intellia Therapeutics

Lead commercial launch of a first-in-class in vivo CRISPR therapy across OK, KS, NE. Develop territory plans, build KOL relationships, present clinical data, manage complex treatment pathways, coordinate hub and cross-functional teams, and drive access and uptake in rare disease settings.

Lead global brand strategy and US marketing for a late-stage gene editing therapy. Drive launch readiness, market development, branding, cross-functional collaboration, vendor management, budget oversight, and deliver commercial insights to support successful commercialization.

Lead strategic engagement with national and large regional commercial payers to secure coverage and reimbursement for a gene editing therapy. Build payer relationships, develop account engagement and evidence materials, inform pricing and contracting (including value-based models), partner cross-functionally on launch readiness, and influence payer policy to ensure patient access and favorable coverage outcomes.